Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [18]
In the citing paper
“Recently, we and others have shown that normal processing of the large amyloid f3 protein precursor ({3-APP) secretes 4-kDa A(3 that is readily detected in human cerebrospinal fluid and in medium conditioned by cultured cells (3)(4)(5)(6).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [3]
In the citing paper
“The demonstration that A-related peptides with the same N terminals as the CTFs documented here are present in conditioned medium of cultured cells (Seubert et al., 1992;Naslund et al., 1994;Simons et al., 1996;Wang et al., 1996;Xu et al., 1998)”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Seubert et al., 1992
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Self-citationMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa-Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,096
Cited by
Items 1,601–1,700 of 1,726
Karn, S., Wei, Z., MacTavish, D., Kabogo, D., Song, M.-S., & Jhamandas, J. H. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_10 · Cited by 1
“Earlier results have shown that Aβ-related peptides are produced constitutively by brain cells and are found in the pM to nM range in the cerebrospinal fluid of normal individuals [9, 165–167].”
ResultPathogenic mechanisms of the Arctic Alzheimer mutation.
Sahlin, C. (2007) · Uppsala University Publications (Uppsala University)
The Biological Basis of Dementias
Racchi, M., & Govoni, S. M. (1999) · Springer eBooks · doi:10.1007/978-88-470-2149-5_2
β‐Amyloid Precursor Protein and Early‐Onset Alzheimer's Disease
Hendriks, L., Jonghe, C. D., Cras, P. P., Martin, J., & Broeckhoven, C. V. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514924.ch11
Panegyres, P. K., & Atkins, E. (2011) · Neuroscience & Medicine · doi:10.4236/nm.2011.23033 · Cited by 2
Ritchie, A. (2004) · Nottingham ePrints (University of Nottingham)
Razzaboni, B. L., Meckelein, B., & Abraham, C. R. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90069-n
Normal Production of the Amyloid β-Protein and the Pathogenesis of Alzheimer’s Disease
Selkoe, D. J., Haass, C., Schlossmacher, M. G., Hung, A. Y., Citron, M., & Teplow, D. B. (1995) · Advances in behavioral biology · doi:10.1007/978-1-4757-9145-7_15
Self-citationDarlington, D. (2014) · Digital Commons - University of South Florida (University of South Florida)
SPECIFIC AMYLOID-BETA OLIGOMERS IN HUMAN CEREBROSPINAL FLUID
Handoko, M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Die Molekularbiologie der Alzheimer-Krankheit
Urmoneit, B. (1999) · Springer eBooks · doi:10.1007/978-3-642-60231-3_11
Fibrillar aggregations of pathogenic pro-vasopressin mutants
Birk, J. (2009) · edoc (University of Basel) · doi:10.5451/unibas-005148703
Association studies on susceptibility genes in Alzheimer disease
Björk, B. F. (2008) · Figshare
Bromander, S. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Molecular Processing Pathways of β-Amyloid Precursor Protein: Therapeutic Implications
Haass, C. (1996) · Springer eBooks · doi:10.1007/978-3-662-03248-0_5 · Cited by 1
TRAFFICKING OF α-SECRETASE ADAM10: NEW INSIGHTS INTO THE MOLECULAR MECHANISM OF MODULATION
Farmacologiche, S., Farmacia, F. D., Farmacotossicologiche, S., & Ciclo, X. (2011)
IMMUNOTHERAPY IN COMBINATION WITH BEHAVIORAL ENRICHMENT IN A CANINE MODEL OF AGING
Davis, P. R. (2014) · UKnowledge (University of Kentucky)
Dynamics of amyloid plaque formation in Alzheimer’s Disease
McCarter, J. F. (2014) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.17434 · Cited by 1
Aβ Conformation Dependent Antibodies and Alzheimer's Disease
Sehlin, D. (2010) · DiVA (Digitala Vetenskapliga Arkivet)
Vascular mechanisms of AD pathogenesis
Grossman, H. A. (2010) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t31c1wp9
Teleha, C. A. (1993) · Current Opinion on Therapeutic Patents · doi:10.1517/13543776.3.2.293
Identification and Role of Non-Beta Components of Senile Plaque Amyloid in Alzheimer’s Disease
Takamaru, Y., Fukatsu, R., Tsuzuki, K., Chiba, H., Kobayashi, K., Nagasawa, S., Aizawa, Y., Fujii, N., Takahata, N., & Ueno, T. (1995) · Advances in behavioral biology · doi:10.1007/978-1-4757-9145-7_23
Gray, C. W., & Karran, E. H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-195-7:217
Bush, A. I., Pettingell, W. H., & Tanzi, R. E. (1994) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-01135-5_16
Nakamura, T. (1995) · Kitakantou igaku/Kitakantō Igaku · doi:10.2974/kmj1951.45.451
der Fakultät, D., & München, L.-M.-U. (2008)
The Complex Pathways to Mechanism-Based Therapeutics in Alzheimer’s Disease
Selkoe, D. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00001-0
Self-citationFluid Biomarkers and Diagnostics
Zetterberg, H., & Blennow, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00021-6
Amyloid-β Protofibril Formation and Neurotoxicity : Implications for Alzheimer’s Disease
Johansson, A. (2007) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Golde, T. E., Lessard, C. B., & Ran, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00005-8
Pathological Changes in the Elderly Human Brain
Mann, D. M. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6001-2_2
Intranasal Aβ Vaccination as an Approach to Treating β-Amyloidosis
Selkoe, D. J. (2003) · Springer eBooks · doi:10.1007/978-3-642-59332-1_5
Self-citationAlbrecht, M. A., & Foster, J. K. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_7
Amyloid- _ Peptide, a Therapeutic Target for Alzheimer’s Disease?
Luo, Y., & Butko, P. (2005) · Oxidative stress and disease · doi:10.1201/9781420026559.ch23 · Cited by 1
Yokoyama, K. (2018) · CRC Press eBooks · doi:10.1201/9781315216003-7
Cellular and animal models of amyloid β-protein amyloidosis
Sisodia, S. S., Borchelt, D., & Price, D. L. (1995) · Elsevier eBooks · doi:10.1016/b978-012286965-5/50012-1
Alzheimer’s Disease and the Sleep–Wake Cycle
Bero, A. W., & Tsai, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00010-3 · Cited by 1
Apple Phenolics and Alzheimer's Disease
Heo, H. J., Kim, D., & Lee, C. Y. (2005) · Oxidative stress and disease · doi:10.1201/9781420026559.ch15
CHANNEL FORMATION BY A NEUROTOXIC BETA AMYLOID PEPTIDE
Lin, M., Mirzabekov, T. A., & Kagan, B. L. (1996)
Microglia and Complement in Alzheimer's Disease with Cerebral Amyloid Angiopathy
Zabel, M. K. (2013) · The Scholars Repository - LLU (Loma Linda University)
Antyborzec, I. (2016) · Dublin City University Open Access Institutional Repository (Dublin City University)
Morphological observation of self-aggregation of β-amyloid 1−40
Gao, Q., Fang, Y., Tang, X., Wu, G., & Lai, K. W. C. (2016) · IEEE International Conference on Nanotechnology (IEEE-NANO) · doi:10.1109/nano.2016.7751415
“In healthy human brain, the concentration of Aβ1-40 is usually at nanomolar level [5].”
BackgroundPeptide Vaccine for Alzheimer’s Disease
Solomon, B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00080-4
Nitrate Chimeras: A New Class of Disease Modifying Agents for the Treatment of Alzheimer's Disease
VandeVrede, L. A. (2014) · Figshare
TRAFFICKING OF ALPHA SECRETASE ADAM10: NEW INSIGHTS INTO THE MOLECULAR MECHANISM OF MODULATION
Saraceno, C. (2012) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/saraceno-claudia_phd2012-02-08
“culture medium, cerebrospinal fluid, and plasma (Haass et al., 1992b; Seubert et al., 1992; Shoji et al., 1992) allowed scientists to quickly establish the biochemical abnormalities caused by APP mutations.”
BackgroundMasters, C. L., & Beyreuther, K. T. (2001) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04399-8_1 · Cited by 2
O'Regan, J. (2014) · TSpace (University of Toronto)
Serem, W. K. (2011) · Louisiana State University · doi:10.31390/gradschool_dissertations.1417
Biomarkers in Cerebrospinal Fluid
Gawinecka, J., Schmitz, M., & Zerr, I. (2017) · Neuromethods · doi:10.1007/978-1-4939-7211-1_14
Immunotherapy for the Treatment of Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00009-4 · Cited by 1
Influence of surface chemistry on the aggregation of beta amyloid peptide
McMasters, M. J. (2006) · Louisiana State University · doi:10.31390/gradschool_dissertations.2681
Amyloid Aggregation-Mitigating Peptides As Potential Alzheimer's Drugs
Bett, C. K. (2009) · Louisiana State University · doi:10.31390/gradschool_dissertations.1865
Metaplasticity Tunes Functional Plasticity in the Rodent Hippocampus
Li, Q. (2015) · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG)) · doi:10.24355/dbbs.084-201503260942-0
Amyloid-beta Causes Autophagy Dysfunction by Inhibiting Protein Prenylation
Smith, K. T. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3vx06f9k · Cited by 1
Begcevic, I. (2018) · TSpace (University of Toronto)
How fluorescent tags modify oligomer size distributions of the Alzheimer-peptide A β (1-40)Preprint
Wägele, J., Sio, S. D., Voigt, B., Balbach, J. J., & Ott, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/372136
“The etiology of all the aforementioned diseases seems to be found in the "defective" folding or "misfolding" of normally soluble, functional peptides and proteins, and their subsequent conversion into intractable aggregates, also known as amyloid fibrils (2).”
BackgroundMethodInfluentialUhrig, M. (2008) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00008496
“Aβ is also present in the cerebrospinal fluid and plasma of normal humans [16, 17].”
Ruolo dei biomarcatori nella diagnostica liquorale della malattia di Alzheimer
Cinquanta, L., & Brusca, I. (2019) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.23736/s1825-859x.19.00028-8
Cysteine in Alzheimer's Disease: Redox Regulation of Protein Functions
Ingale, S. P., Patil, R., & Upaganlawar, A. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch013
JAMISON, J. (2003) · Elsevier eBooks · doi:10.1016/b978-0-443-07193-5.50014-5
Molecular biology and pathology of Alzheimer's disease
Beyreuther, K. T., Multhaup, G., & Masters, C. L. (1993) · Elsevier eBooks · doi:10.1016/b978-0-444-81470-8.50011-9
Effects of anle138b treatment on amyloid-β neurotoxicity
Thomas, C. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8233
Tosonyan, S. A. A. (2018) · OPUS - Open Publications of UTS Scholars (University of Technology Sydney)
McKeever, P. M. (2018) · TSpace (University of Toronto)
Molecular basis of amyloid-β chaperone activity of lipocalin-type prostaglandin D synthase (L-PGDS)
Kannaian, B. (2019) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/137482
Solomon, B., Hanan, E., Koppel, R., Frankel, D., Ophir, I., & Schenck, D. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_30
Amyloid beta resistance and the Warburg effect: Re-examining Alzheimer's disease
Newington, J. T. (2013) · Scholarship@Western (Western University)
Studies on the use of glycosaminoglycans for the treatment of Alzheimer's Disease
Cui, H. (2012) · UTAS Research Repository · doi:10.25959/23206211
Cerebral amyloid angiopathy : new insights from transgenic mice
Herzig, M. C. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003642738
Anchoring of Amyloid-β onto Polyunsaturated Phospholipid Membranes
Yuan, R., & Huang, H. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2016488
Merino, P. (2019) · Wiley eBooks · doi:10.1002/9783527813421.ch9
Hoyer, S., & Frölich, L. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6400-6_47
Siman, R., & Greenberg, B. (1996) · Humana Press eBooks · doi:10.1007/978-1-59259-466-5_10
The βA4 amyloid precursor protein gene and Alzheimer’s disease
Hendriks, L., & Broeckhoven, C. V. (1996) · Springer eBooks · doi:10.1007/978-3-642-60659-5_5
Heinonen, O., Soininen, H. S., Syrjänen, S., Neittaanmäki, H., Paljärvi, L., Kosunen, O., Talasniemi, S., Syrjänen, K. J., & Riekkinen, P. (1995) · Advances in behavioral biology · doi:10.1007/978-1-4757-9145-7_24
Gandy, S., & Greengard, P. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_10 · Cited by 2
Ablation of cell-specific cholesterol synthesis affects cerebral β-amyloidosis
Spieth, L. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9780
Understanding Alzheimer’s Disease: A Multidisciplinary Perspective
Akbarzadehmoallemkoalei, M., Yektakasmaei, M. P., Tabar, S. S. S., Zolfaghari, K., Noorikoloori, S., Niktalab, P., Rouzrokh, S., Sheykhzadeh, Z., Sanavi, M. A., Dozdouzan, M. A., et al. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_14 · Cited by 1
Toxicology of the Brain Barrier System in Brain’s Health and Diseases
Liu, L. L., & Zheng, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00225-4
Fluid and Imaging Markers of Vascular Disease
Rosenberg, G. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_7
Katzman, R. (1994) · Comprehensive physiology · doi:10.1002/j.2040-4603.1994.tb01684.x
“APP is normally cleaved at a site in the middle of the P-amyloid sequence and the long, soluble portion N terminal to the cleavage site is secreted as protease-nexin I1 (61, 179, 182, 205).”
Structural heterogeneity reveals distinct amyloidopathies in Alzheimer’s diseasePreprint
Novotný, J., Čarná, M., Lyburn, I. D., Kuruvilla, T., Stokin, G. B., & Initiative, T. A. D. N. (2025) · medRxiv · doi:10.1101/2025.11.17.25340406
Amyloid β hypothesis in the development of therapeutic agents for Alzheimer's disease
Adeniji, A. O., Johnson, C., & Mody, V. V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30008-0.00020-x
Chromosome Missegregation in Alzheimer's Disease Caused by Presenilin 1
Boeras, D. I. (2005) · Digital Commons - University of South Florida (University of South Florida)
Beta Amyloid (Aβ) as a Therapeutic Target in Alzheimer’s Disease
Lieberburg, I. M. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_8
Self-citationA study of the role of presenilin (1) in regulating synaptic function at hippocampal synapses
Yu, L. M. Y. (2010) · UCL Discovery (University College London)
Wang, Z., Jin, M., Hong, W., Liu, W., Reczek, D., Lagomarsino, V. N., Hu, Y., Weeden, T., Frosch, M. P., Young‐Pearse, T. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26574274
Self-citationLiu, L. L., Shen, X., Gu, H., Zhao, G., Du, Y., & Zheng, W. (2024) · Figshare · doi:10.6084/m9.figshare.26585868
Wang, Z., Jin, M., Hong, W., Liu, W., Reczek, D., Lagomarsino, V. N., Hu, Y., Weeden, T., Frosch, M. P., Young‐Pearse, T. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26574286
Self-citationWang, Z., Jin, M., Hong, W., Liu, W., Reczek, D., Lagomarsino, V. N., Hu, Y., Weeden, T., Frosch, M. P., Young‐Pearse, T. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26574277
Self-citationWang, Z., Jin, M., Hong, W., Liu, W., Reczek, D., Lagomarsino, V. N., Hu, Y., Weeden, T., Frosch, M. P., Young‐Pearse, T. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26574295
Self-citationWang, Z., Jin, M., Hong, W., Liu, W., Reczek, D., Lagomarsino, V. N., Hu, Y., Weeden, T., Frosch, M. P., Young‐Pearse, T. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26574283
Self-citationWang, Z., Jin, M., Hong, W., Liu, W., Reczek, D., Lagomarsino, V. N., Hu, Y., Weeden, T., Frosch, M. P., Young‐Pearse, T. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26574298
Self-citation
Metadata
- Authors
- Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., & Schenk, D.
- Affiliations
- Austrian Academy of Sciences (AT)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6393
- Pages
- 325-327
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086278983
- Cited by
- 1,731
- References
- 28
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 32 · 2023: 19 · 2022: 22 · 2021: 31 · 2020: 28 · 2019: 25 · 2018: 35 · 2017: 39 · 2016: 31 · 2015: 48 · 2014: 46 · 2013: 39 · 2012: 50
- FWCI
- 72.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, cerebrospinal fluid, plasma, conditioned medium, sandwich ELISA, affinity chromatography, epitope-specific antibodies, amyloid deposition, diagnostic biomarkers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Antibodies, Monoclonal, Brain, Cells, Cultured, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Humans, Molecular Sequence Data, Peptide Fragments, Radioimmunoassay, Solubility, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.